Key Highlights

  • Net sales were USD 206 million versus USD 214 million, and the net loss was USD 5.6 million.
  • Diluted EPS was a loss of USD 0.30, and adjusted diluted EPS was a loss of USD 0.11.
  • Hiya active monthly subscribers rose 18% sequentially to 195,500, and Core Nutritional customers were 356,000.
  • The company ended the quarter with USD 179 million in cash and no debt, and updated its fiscal 2026 outlook.

Consolidated Results

USANA Health Sciences, Inc. (NYSE:USNA) reported fiscal third-quarter 2026 results for the quarter ended October 3, 2026. Net sales were USD 206 million, down 4% from USD 214 million, which includes a USD 4 million, or 2%, foreign exchange benefit, and down 8% sequentially. The net loss attributable to USANA was USD 5.6 million, compared with USD 6.5 million, and diluted EPS was a loss of USD 0.30, compared with a loss of USD 0.36. Adjusted diluted EPS was a loss of USD 0.11, compared with a loss of USD 0.15.

Adjusted EBITDA was USD 12.1 million, compared with USD 13.8 million, a decrease of 13% year over year and 44% sequentially. The figures exclude the noncontrolling interest of 21.2% in Hiya.

Analyst estimates were EPS of USD 0.11 against reported EPS of negative USD 0.11, and Revenue of USD 217.4 million against reported revenue of USD 205.9 million.

Segments, Cash and Strategy

Core Nutritional net sales were USD 171 million, down 3% (down 6% in constant currency) and down 11% sequentially, with 356,000 active customers, down 8%. Asia Pacific net sales were USD 138 million, and Americas and Europe net sales were USD 33 million, down 11%.

Hiya Health net sales were USD 32 million, up 2% year over year and 12% sequentially, with 195,500 active monthly subscribers, up 1% year over year and 18% sequentially. Rise Wellness net sales were USD 4 million, down 45%. Chairman and Chief Executive Officer Kevin Guest said Hiya increased Marketing spend as customer Acquisition responded, which pressured margins, and that Core Nutritional expanded its operating Margin from a year ago on a leaner cost structure despite lower net sales.

The company generated USD 8 million of free Cash Flow in the quarter and USD 36 million year to date. It ended the quarter with USD 179 million in cash and cash equivalents and no debt, and inventory of USD 93 million was down 13% from year-end 2025. The company did not repurchase shares in the quarter and has USD 34 million remaining under its repurchase authorization.

The chief executive said rebuilding the Core Nutritional active customer base is the top priority, and that active customers in Southeast Asia Pacific grew 3% sequentially. He said the company is evolving its Brand Partner incentive plan to reward growth in active customers. At Hiya, net active monthly subscribers rose by 29,500 sequentially and net sales through Target and Amazon more than doubled from the second quarter.

Fiscal 2026 Outlook and Correction

The company updated its fiscal 2026 outlook to consolidated net sales approaching USD 900 million, from USD 910 million, and adjusted EBITDA of USD 77 million, from USD 80.5 million as corrected. Core Nutritional net sales are guided at USD 740 million, Hiya at USD 130 million, up from USD 125 million, and Rise Wellness at USD 30 million, down from USD 35 million. Adjusted diluted EPS is guided at USD 0.55.

The company also corrected its second-quarter 2026 adjusted EBITDA reconciliation, because the USD 29.1 million Hiya Goodwill Impairment had been added back in full rather than net of the USD 6.2 million noncontrolling interest share. Corrected second-quarter adjusted EBITDA attributable to USANA is USD 21.7 million, and the August fiscal 2026 outlook is USD 80.5 million. The correction has no effect on reported GAAP results.

Items to Follow

Items to follow are Core Nutritional active customers, Hiya subscriber growth and margins, Rise Wellness net sales and fourth-quarter results against the updated outlook.